Mayville Engineering Company, Inc.: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Nov 3, 2020 and accepted by EDGAR at Nov 3, 2020, 17:00 ET.
Management's discussion and analysis
As filed, 41,964 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to assist in the understanding and assessing the trends and significant changes in our results of operations and financial condition. Historical results may not be indicative of future performance. This discussion includes forward-looking statements that reflect our plans, estimates and beliefs. Such statements involve risks and uncertainties. Our actual results may differ materially from those contemplated by these forward-looking statements as a result of various factors, including those set forth in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019, as such were previously supplemented and amended in Part II, Item 1A, “Risk Factors” of our Quarterly Report on Form 10-Q for the three months ended March 31, 2020, and “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q. This discussion should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019 and our unaudited condensed consolidated financial statements and the notes thereto included in Part I, Item I of this Quarterly Report on Form 10-Q. In this discussion, we use certain non-GAAP financial measures. Explanation of these non-GAAP financial measures and reconciliation to the most directly comparable GAAP financial measures are included in this Management Discussion and Analysis of Financial Condition and Results of Operations. Investors should not consider non-GAAP financial measures in isolation or as substitutes for financial information presented in compliance with GAAP.
All amounts are presented in thousands except share amounts, per share data, years and ratios.
Overview
MEC is a leading U.S.-based value-added manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components. Our customers operate in diverse end markets, including heavy-and medium-duty commercial vehicles, construction & access equipment, powersports, agriculture, military and other end markets. We have developed long-standing relationships with our blue-chip customers based upon a high level of experience, trust and confidence.
Our one operating segment focuses on producing metal components that are used in a broad range of heavy-and medium-duty commercial vehicles, construction & access equipment, powersports, agricultural, military and other products.
In May 2019, we completed our IPO. In conjunction with the IPO, the Company’s legacy business converted from an S corporation to a C corporation. As a result, the consolidated business is subject to paying federal and state corporate income taxes on its taxable income from May 9, 2019 forward.
COVID-19 Impact
COVID-19 has had and will continue to have a negative impact on our business, financial condition, cash flows, and results of operations, although the full extent is uncertain.
For the three and nine months ended September 30, 2020, net sales reflected the significant disruption we encountered primarily due to COVID-19 with customer shutdowns, demand changes, and continued destocking, which were most apparent in the Commercial Vehicle, Agriculture and Construction & Access Equipment end markets served. Despite MEC and its customer base carrying the essential business designation, customer production facilities shut down 5 – 6 weeks on average during the second quarter due to COVID-19. As a direct result of the customer shutdowns, MEC temporarily halted production at some of its facilities during the second quarter. Customer manufacturing facilities gradually reopened toward the end of the second quarter, but MEC production volumes remain below pre-pandemic levels as of the end of the third quarter with all MEC facilities open. Despite the decline in volumes for the second and third quarters, all existing customer relationships and manufacturing programs remain intact. While end markets have started to stabilize, we have improved our near- and long-term cost structure through facility and process optimization and are actively working with our customers to grow our partnerships while pursuing incremental sales through a wide range of new customer and market opportunities.
The future financial effects of COVID-19 are unknown due to many factors. These factors include uncertainty of the effectiveness of governmental actions to address COVID-19, including health, monetary and fiscal policies, the effect of elevated levels of sovereign and state debt, capital market disruptions, changes in demand and pricing, trade agreements, other geopolitical events, and volatility in the price of many commodities. As a result, predicting the Company’s forecasted financial performance is difficult and subject to many assumptions.
The Company’s first priority has been to safeguard the health and well-being of its employees while fulfilling its obligations as an essential business serving its customer base. This proactive approach has kept employees safe and production facilities operational based on customer demand. Our goal is to continue to successfully manage through the effects of COVID-19 and strengthen our position serving customers in the future.
How We Assess Performance
Net Sales. Net sales reflect sales of our components and products net of allowances for returns and discounts. In addition to COVID-19, several factors affect our net sales in any given period, including general economic conditions, weather, timing of acquisitions and the production schedules of our customers. Net sales are recognized at the time of shipment to the customer.
Manufacturing Margins. Manufacturing margins represents net sales less cost of sales. Cost of sales consists of all direct and indirect costs used in the manufacturing process, including raw materials, labor, equipment costs, depreciation, lease expenses, subcontract costs and other directly related overhead costs. Our cost of sales is directly affected by the fluctuations in commodity prices, primarily sheet steel and aluminum, but these changes are largely mitigated by contractual agreements with our customers that allow us to pass through these price changes based upon certain market indexes.
Depreciation and Amortization. We carry property, plant and equipment on our balance sheet at cost, net of accumulated depreciation and amortization. Depreciation on property, plant and equipment is computed on a straight-line basis over the estimated useful life of the asset. Amortization expense is the periodic expense related to leasehold improvements and intangible assets. Leasehold improvements are amortized over the lesser of the life of the underlying asset or the remaining lease term. Our intangible assets were recognized as a result of certain acquisitions and are generally amortized on a straight-line basis over the estimated useful lives of the assets.
Other Selling, General, and Administrative Expenses. Other selling, general and administrative expenses consist primarily of salaries and personnel costs for our sales and marketing, finance, human resources, information systems, administration and other certain managerial employees and certain corporate level administrative expenses such as incentive compensation, audit, accounting, legal and other consulting and professional services, travel, and insurance.
Other Key Performance Indicators
EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin
EBITDA represents net income before interest expense, provision (benefit) for income taxes, depreciation and amortization. EBITDA Margin represents EBITDA as a percentage of net sales for each period.
Adjusted EBITDA represents EBITDA before transaction fees incurred in connection with the acquisition of Defiance Metal Products Co., Inc. (DMP) and the IPO, the loss on debt extinguishment relating to our December 2018 credit agreement, non-cash purchase accounting charges including costs recognized on the step-up of acquired inventory and contingent consideration fair value adjustments, one-time increases in deferred compensation and long-term incentive plan expenses related to the IPO, stock-based compensation, and restructuring expenses related to the closure of the Greenwood facility. Adjusted EBITDA Margin represents Adjusted EBITDA as a percentage of net sales for each period. These metrics are supplemental measures of our operating performance that are neither required by, nor presented in accordance with, GAAP. These measures should not be considered as an alternative to net income or any other performance measure derived in accordance with GAAP as an indicator of our operating performance. We present Adjusted EBITDA and Adjusted EBITDA Margin as management uses these measures as key performance indicators, and we believe they are measures frequently used by securities analysts, investors and other parties to evaluate companies in our industry. These measures have limitations as analytical tools and should not be considered in isolation or as substitutes for analysis of our results as reported under GAAP.
Starting in the first quarter of 2020, we excluded stock-based compensation expense from Adjusted EBITDA. Management excludes this charge when evaluating the performance of the business because it is a non-cash charge, and the Company is able to fund vesting obligations through treasury shares. Further, the exclusion of these charges aligns with the calculation of Adjusted EBITDA for purposes of our covenant calculations under the Credit Agreement. And finally, revaluations of grant date fair values can vary significantly with the passage of time without any accounting impact. For example, the fair value of the stock-based compensation awards granted in May 2019 would have been approximately half of that value had they been granted at the end of this quarter.
Our calculation of EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to the similarly named measures reported by other companies. Potential differences between our measures of EBITDA and Adjusted EBITDA compared to other similar companies’ measures of EBITDA and Adjusted EBITDA may include differences in capital structure and tax positions.
The following table presents a reconciliation of net income (loss), the most directly comparable measure calculated in accordance with GAAP, to Adjusted EBITDA, and the calculation of Adjusted EBITDA Margin for each of the periods presented.
| Three Months Ended September 30, 2020 | 2019 | Nine Months Ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Net income (loss) | $(1,100) | $9,746 | $(8,064) | $(3,079) |
| Interest expense | 647 | 987 | 2,110 | 5,811 |
| Provision (benefit) for income taxes | 733 | 2,512 | (1,101) | (231) |
| Depreciation and amortization | 7,894 | 8,297 | 24,334 | 24,652 |
| EBITDA | 8,174 | 21,543 | 17,279 | 27,153 |
| Loss on the extinguishment of debt | — | — | — | 154 |
| Costs recognized on step-up of acquired inventory | — | — | — | 395 |
| Contingent consideration revaluation | — | (9,598) | — | (6,054) |
| Deferred compensation expense specific to IPO | — | — | — | 10,159 |
| Long term incentive plan expense specific to IPO | — | — | — | 9,921 |
| Other IPO and DMP acquisition related expenses | — | 900 | — | 5,288 |
| IPO stock-based compensation expense | — | 725 | 1,029 | 1,146 |
| Stock based compensation expense | 978 | 613 | 2,690 | 989 |
| Greenwood restructuring charges | 687 | — | 2,524 | — |
| Adjusted EBITDA | $9,839 | $14,183 | $23,522 | $49,151 |
| Net sales | $91,075 | $128,511 | $262,262 | $417,373 |
| EBITDA Margin | 9.0% | 16.8% | 6.6% | 6.5% |
| Adjusted EBITDA Margin | 10.8% | 11.0% | 9.0% | 11.8% |
Consolidated Results of Operations
Three Months Ended September 30, 2020 Compared to Three Months Ended September 30, 2019
| Three Months Ended September 30, 2020 Amount | % of Net Sales | 2019 Amount | % of Net Sales | Increase (Decrease) Amount Change | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $91,075 | 100.0% | $128,511 | 100.0% | $(37,436) | -29.1% |
| Cost of sales | 81,340 | 89.3% | 113,941 | 88.7% | (32,601) | -28.6% |
| Manufacturing margins | 9,735 | 10.7% | 14,570 | 11.3% | (4,835) | -33.2% |
| Amortization of intangibles | 2,677 | 2.9% | 2,677 | 2.1% | — | 0.0% |
| Profit sharing, bonuses and deferred compensation | 2,288 | 2.5% | 678 | 0.5% | 1,610 | 237.5% |
| Employee stock ownership plan expense | — | 0.0% | 1,500 | 1.2% | (1,500) | -100.0% |
| Other selling, general and administrative expenses | 4,490 | 4.9% | 6,068 | 4.7% | (1,578) | -26.0% |
| Contingent consideration revaluation | — | 0.0% | (9,598) | -7.5% | 9,598 | 100.0% |
| Income from operations | 280 | 0.3% | 13,245 | 10.3% | (12,965) | -97.9% |
| Interest expense | (647) | 0.7% | (987) | 0.8% | (340) | -34.4% |
| Provision for income taxes | 733 | 0.8% | 2,512 | 2.0% | (1,779) | -70.8% |
| Net income (loss) and comprehensive income (loss) | $(1,100) | -1.2% | $9,746 | 7.6% | $(10,846) | -111.3% |
| EBITDA | $8,174 | 9.0% | $21,543 | 16.8% | $(13,369) | -62.1% |
| Adjusted EBITDA | $9,839 | 10.8% | $14,183 | 11.0% | $(4,344) | -30.6% |
Net Sales. Net sales were $91,075 for the three months ended September 30, 2020 as compared to $128,511 for the three months ended September 30, 2019, a decrease of $37,436, or 29.1%. This change is due to volume reductions across nearly all end markets served driven by COVID-19 and the continued customer destocking activities within the Agriculture and Construction & Access Equipment end markets served. Despite the volume declines, all existing customer relationships and manufacturing programs remain intact.
Manufacturing Margins. Manufacturing margins were $9,735 for the three months ended September 30, 2020 as compared to $14,570 for the three months ended September 30, 2019, a decrease of $4,835, or 33.2%. The decline was driven by the aforementioned sales volume reductions resulting in under-absorbed manufacturing costs. In addition, $687 of restructuring costs were charged to cost of sales in the current period related to the Greenwood facility closure, the details of which are outlined in Note 21 of the Condensed Consolidated Financial Statements.
Manufacturing margin percentages were 10.7% for the three months ended September 30, 2020, as compared to 11.3% for the three months ended September 30, 2019, a decline of 60 basis points. This decline was mostly attributable to lower sales volumes due to COVID-19 resulting in under-absorbed fixed overhead costs along with the $687 of restructuring charges to cost of sales in the current period related to the Greenwood facility closure. Based on the business realignment and cost reduction initiatives enacted, the Company believes manufacturing margin percentages should improve beyond historical percentages when volumes return to historical levels.
Amortization of Intangibles Expense. Amortization of intangibles expense was $2,677 for both the three months ended September 30, 2020 and 2019.
Profit Sharing, Bonuses and Deferred Compensation Expenses. Profit sharing, bonuses, and deferred compensation expenses were $2,288 for the three months ended September 30, 2020 as compared to $678 for the three months ended September 30, 2019, an increase of $1,610, or 237.5%. This change was primarily driven by the re-establishment of some year-to-date discretionary bonus and 401(k) related accruals that had been eliminated in the second quarter this year due to the uncertainty caused by COVID-19 at that time.
Employee Stock Ownership Plan Expense. Employee stock ownership plan expense was zero for the three months ended September 30, 2020 as compared to $1,500 for the three months ended September 30, 2019, a decrease of $1,500, or 100.0%. Prior to December 31, 2019, the annual ESOP contribution was discretionary except that it must have been at least 3% of the compensation for all safe harbor participants for the plan year. Beginning in 2020, all contributions are discretionary. The change is due to the decision to eliminate this particular discretionary contribution for the fiscal year 2020 as a result of lower financial performance due to the impacts of COVID-19.
Other Selling, General and Administrative Expenses. Other selling, general and administrative expenses were $4,490 for the three months ended September 30, 2020 as compared to $6,068 for the three months ended September 30, 2019, a decrease of $1,578, or 26.0%. The prior year period includes an additional $900 of one-time IPO related expenses. Excluding the one-time charges, these expenses decreased $678 driven by synergies achieved through the integration of DMP, lower travel and entertainment expenses in the current period due to COVID-19 restrictions, and other cost saving initiatives.
Contingent Consideration Revaluation. The DMP purchase agreement provided for a payout to the previous shareholders of DMP of $7,500, but not more than $10,000 if a certain level of EBITDA was generated during the twelve-month period ended September 30, 2019. We estimated the fair value of the contingent consideration payable balance of $6,076 as of the acquisition date of December 14, 2018. We then remeasured the fair value each quarter through September 30, 2019, with the change recorded as a contingent consideration revaluation adjustment. Based on our calculations in accordance with the purchase agreement, and as agreed to by DMP’s former shareholders, it was determined DMP’s EBITDA fell short of the payout threshold and as a result, the contingent consideration payable balance of $9,598 was adjusted to zero, resulting in income of this amount for the three months ended September 30, 2019.
Interest Expense. Interest expense was $647 for the three months ended September 30, 2020 as compared to $987 for the three months ended September 30, 2019, a decrease of $340, or 34.4%. The change is due to lower borrowings during the third quarter of 2020 as compared to the third quarter of 2019 along with lower interest rates attributable to the more favorable terms afforded under the Amended & Restated Credit Agreement.
Provision for Income Taxes. Income tax expense was $733 for the three months ended September 30, 2020 as compared to $2,512 for the three months ended September 30, 2019. Please reference Note 9 of the Condensed Consolidated Financial Statements for more specifics. As of September 30, 2020, our federal operating loss (NOL) carryforward was approximately $23,000 driven by the pretax losses incurred in the current year along with the entirety of the prior year. The NOL does not expire and will be used to offset future pretax income. We expect our long-term effective tax rate to be 26%, based on current tax regulations.
Net Income (Loss) and Comprehensive Income (Loss). Net loss and comprehensive loss were $1,100 for the three months ended September 30, 2020 as compared to net income and comprehensive income of $9,746 for the three months ended September 30, 2019. The decrease of $10,846 was primarily due to the reversal of the contingent consideration payable during the prior period and other previously discussed items.
EBITDA and EBITDA Margin. EBITDA and EBITDA Margin were $8,174 and 9.0%, respectively, for the three months ended September 30, 2020 as compared to $21,543 and 16.8%, respectively, for the three months ended September 30, 2019. The
$13,369 decrease in EBITDA was primarily due to the reversal of the contingent consideration payable during the prior period and the Greenwood restructuring costs and adverse impacts of COVID-19 in the current period.
Adjusted EBITDA and Adjusted EBITDA Margin. Adjusted EBITDA and Adjusted EBITDA Margin were $9,839 and 10.8%, respectively, for the three months ended September 30, 2020, as compared to $14,183 and 11.0%, respectively, for the three months ended September 30, 2019. The decrease in Adjusted EBITDA of $4,344 was primarily due to the adverse impacts of COVID-19 in the current period.
Nine Months Ended September 30, 2020 Compared to Nine Months Ended September 30, 2019
| Nine Months Ended September 30, 2020 Amount | % of Net Sales | 2019 Amount | % of Net Sales | Increase (Decrease) Amount Change | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $262,262 | 100.0% | $417,373 | 100.0% | $(155,111) | -37.2% |
| Cost of sales | 241,838 | 92.2% | 362,689 | 86.9% | (120,851) | -33.3% |
| Manufacturing margins | 20,424 | 7.8% | 54,684 | 13.1% | (34,260) | -62.7% |
| Amortization of intangibles | 8,030 | 3.1% | 8,030 | 1.9% | — | 0.0% |
| Profit sharing, bonuses and deferred compensation | 4,807 | 1.8% | 25,258 | 6.1% | (20,451) | -81.0% |
| Employee stock ownership plan expense | — | 0.0% | 4,500 | 1.1% | (4,500) | -100.0% |
| Other selling, general and administrative expenses | 14,642 | 5.6% | 20,296 | 4.9% | (5,654) | -27.9% |
| Contingent consideration revaluation | — | 0.0% | (6,054) | -1.5% | 6,054 | 100.0% |
| Gain (loss) from operations | (7,055) | -2.7% | 2,655 | 0.6% | (9,710) | -365.7% |
| Interest expense | (2,110) | 0.8% | (5,811) | 1.4% | (3,701) | -63.7% |
| Loss on extinguishment of debt | — | 0.0% | (154) | 0.0% | (154) | -100.0% |
| Benefit for income taxes | (1,101) | -0.4% | (231) | -0.1% | 870 | 376.6% |
| Net loss and comprehensive loss | $(8,064) | -3.1% | $(3,079) | -0.7% | $4,985 | 161.9% |
| EBITDA | $17,279 | 6.6% | $27,153 | 6.5% | $(9,874) | -36.4% |
| Adjusted EBITDA | $23,522 | 9.0% | $49,151 | 11.8% | $(25,629) | -52.1% |
Net Sales. Net sales were $262,262 for the nine months ended September 30, 2020 as compared to $417,373 for the nine months ended September 30, 2019, a decrease of $155,111, or, 37.2%. This change is primarily attributed to volume reductions across nearly all end markets served driven by COVID-19 and the continued impact of market demand changes and related destocking activities, which was most apparent in the Commercial Vehicle, Agricultural, and Construction & Access Equipment end markets served. Despite the volume declines, all existing customer relationships and manufacturing programs remain intact.
Manufacturing Margins. Manufacturing margins were $20,424 for the nine months ended September 30, 2020 as compared to $54,684 for the nine months ended September 30, 2019, a decrease of $34,260, or, 62.7%. The decline was mainly driven by the aforementioned volume reductions driven by COVID-19 along with the continued impact of market demand changes and destocking activities, and $2,524 of restructuring costs related to the Greenwood facility consolidation, the details of which are outlined in Note 21 of the Condensed Consolidated Financial Statements. In addition, costs of sales includes approximately $775 of inventory obsolescence and health care charges specific to the estimated potential impacts of COVID-19.
Our traditional methods of determining inventory obsolescence and health care accruals significantly rely upon historical data. When estimating the approximately $775 of COVID-19 reserves during the first quarter of the current year, we had neither historical information, nor much other data from which to compute an estimated impact for this type of event. Nevertheless, the Company believes the obvious risk posed by the pandemic may have a financial impact in these areas. This charge for these COVID-19 specific accruals represents our best good faith estimate of the potential financial impact to the Company based on information available to us. Due to the continued risk posed by COVID-19, these reserves have remained mostly unchanged since establishment. We will continue to evaluate and report on our position with respect to these reserves as we work through the pandemic.
Manufacturing margin percentages were 7.8% for the nine months ended September 30, 2020 as compared to 13.1%, of net sales for the nine months ended September 30, 2019, a decline of 530 basis points. This decline was mostly attributable to the aforementioned impacts of COVID-19, market demand changes, destocking activities, Greenwood facility restructuring costs, and COVID-19 specific accruals. Based on the cost reduction initiatives enacted, the Company believes manufacturing margin percentages should improve beyond historical percentages when volumes return to historical levels.
Amortization of Intangibles Expense. Amortization of intangibles expense was $8,030 for both the nine months ended September 30, 2020, and 2019.
Profit Sharing, Bonuses and Deferred Compensation Expense. Profit sharing, bonuses and deferred compensation expenses were $4,807 for the nine months ended September 30, 2020 as compared to $25,258 for the nine months ended September 30, 2019, a decrease of $20,451, or 81.0%. The prior year included $20,080 of one-time IPO expenses, including $10,159 for deferred compensation and $9,921 for long-term incentive plan. Excluding these items from the prior year, these expenses decreased by $371. The decrease is primarily due to lower financial performance mostly from the impacts of COVID-19.
Employee Stock Ownership Plan Expense. Employee stock ownership plan expense was zero for the nine months ended September 30, 2020 as compared to $4,500, for the nine months ended September 30, 2019, a decrease of $4,500, or 100.0%. Prior to December 31, 2019, the annual ESOP contribution was discretionary except that it must have been at least 3% of the compensation for all safe harbor participants for the plan year. Beginning in 2020, all contributions are discretionary. The change is due to the decision to eliminate this particular discretionary contribution for the fiscal year 2020 as a result of lower financial performance mostly due to the impacts of COVID-19.
Other Selling, General and Administrative Expenses. Other selling, general and administrative expenses were $14,642 for the nine months ended September 30, 2020 as compared to $20,296 for the nine months ended September 30, 2019, a decrease of $5,654, or 27.9%. The prior year period includes $5,288 of one-time other IPO and DMP acquisition related expenses. Excluding these one-time charges, these expenses decreased $366. The decrease was driven by synergies achieved through the integration of DMP, lower travel and entertainment expenses in the current period due to COVID-19 restrictions, and other cost saving initiatives initiated in the current year.
Contingent Consideration Revaluation. The DMP purchase agreement provided for a payout to the previous shareholders of DMP of $7,500, but not more than $10,000 if a certain level of EBITDA was generated during the twelve-month period ended September 30, 2019. We estimated the fair value of the contingent consideration payable balance of $6,076 as of the acquisition date of December 14, 2018. We then remeasured the fair value each quarter through September 30, 2019, with the change recorded as a contingent consideration revaluation adjustment. Based on our calculations in accordance with the purchase agreement, and as agreed to by DMP’s former shareholders, it was determined DMP’s EBITDA fell short of the payout threshold and as a result, the contingent consideration payable balance of $9,598 was adjusted to zero, resulting in income of $6,054 for the nine months ended September 30, 2019.
Interest Expense. Interest expense was $2,110 for the nine months ended September 30, 2020 as compared to $5,811 for the nine months ended September 30, 2019, a decrease of $3,701, or 63.7%. The change is due to lower borrowings during the current period as compared to the same prior year period along with lower interest rates attributable to the more favorable terms afforded under the Amended & Restated Credit Agreement.
Benefit for Income Taxes. Income tax benefit was $1,101 for the nine months ended September 30, 2020 as compared to $231 for the nine months ended September 30, 2019. The increase is due to a greater pretax loss in the current period. Please reference Note 9 of the Condensed Consolidated Financial Statements for more specifics. As of September 30, 2020, our federal NOL carryforward was approximately $23,000 driven by the pretax losses incurred during the current year and the entirety of the prior year. The NOL does not expire and will be used to offset future pretax income. We expect our long-term effective tax rate to be 26%, based on current tax regulations.
Net Loss and Comprehensive Loss. Net loss and comprehensive loss were $8,064 for the nine months ended September 30, 2020 as compared to $3,079 for the nine months ended September 30, 2019. The increase of $4,984 was due to the previously discussed items.
EBITDA and EBITDA Margin. EBITDA and EBITDA Margin were $17,279 and 6.6%, respectively, for the nine months ended September 30, 2020 as compared to $27,153 and 6.5%, respectively, for the nine months ended September 30, 2019. The $9,874 decrease in EBITDA was primarily due to the reduction in sales volumes driven by COVID-19, the decline in market demand, destocking activities, along with the Greenwood facility closure costs in the current period collectively having a greater impact than the one-time IPO costs incurred during the prior period.
Adjusted EBITDA and Adjusted EBITDA Margin. Adjusted EBITDA and Adjusted EBITDA Margin were $23,522 and 9.0%, respectively, for the nine months ended September 30, 2020 as compared to $49,151 and 11.8%, respectively, for the nine months ended September 30, 2019. The decrease in Adjusted EBITDA of $25,629 was primarily due to the reduction in sales volumes in the current period driven by COVID-19, the decline in market demand, and destocking activities.
Liquidity and Capital Resources
Cash Flows Analysis
(in thousands)
| Nine Months Ended September 30, 2020 | 2019 | Increase (Decrease) $Change | % Change | |
|---|---|---|---|---|
| Net cash provided by operating activities | $19,291 | $16,424 | 2,867 | 17.5% |
| Net cash used in investing activities | (3,434) | (26,768) | 23,334 | 87.2% |
| Net cash provided by (used in) financing activities | (15,748) | 7,256 | (23,004) | -317.0% |
| Net change in cash | $109 | $(3,088) | $3,197 | 103.5% |
Operating Activities. Cash provided by operating activities was $19,291 for the nine months ended September 30, 2020, as compared to $16,424 for the nine months ended September 30, 2019. The $2,867, or 17.5% increase in operating cash flows was primarily due to a greater reduction in inventory, prepaids and other assets, along with beneficial changes in a variety of other operating assets and liability categories in the current year as compared to the same prior year period. Changes to pricing, payment terms and credit terms did not have a significant impact on changes to working capital items, or any other element of the operating cash flow activities, for the periods presented.
Investing Activities. Cash used in investing activities was $3,434 for the nine months ended September 30, 2020, as compared to $26,768 for the nine months ended September 30, 2019. The $23,334, or 87.2% decrease in cash used in investing activities was driven by our capital spend changing from a focus on investments in new technology and automation in 2019 to leveraging those investments and preserving cash in 2020. In addition, due to the Greenwood facility closure, the company generated more proceeds for the sale of equipment in the current period as compared to the same prior year period.
Financing Activities. Cash used in financing activities was $15,748 for the nine months ended September 30, 2020, as compared to cash provided by financing activities of $7,256 for the nine months ended September 30, 2019. The $23,004 change was driven by the use of operating cash flow in the current period to pay down debt and purchase of stock as compared to net cash provided by financing activities in the prior year driven by the IPO proceeds.
Amended and Restated Credit Agreement
On September 26, 2019, and as last amended as of June 30, 2020, we entered into the amended and restated credit agreement (Credit Agreement) with certain lenders and Wells Fargo Bank, National Association, as administrative agent (the Agent). The Credit Agreement provides for a $200,000 Revolving Loan, with a letter of credit sub-facility in an aggregate amount not to exceed $5,000, and a swingline facility in an aggregate amount of $20,000. The Credit Agreement also provides for an additional $100,000 of capacity through an accordion feature. All amounts borrowed under the Credit Agreement mature on September 26, 2024.
Our obligations under the Credit Agreement are secured by first priority security interests in substantially all of our personal property and guaranteed by, and secured by first priority security interests in, substantially all of the personal property of, our direct and indirect subsidiaries: Center Manufacturing, Inc., Center Manufacturing Holdings, Inc., Center—Moeller Products LLC, Defiance Metal Products Co., Defiance Metal Products of Arkansas, Inc., Defiance Metal Products of PA., Inc. and Defiance Metal Products of WI, Inc.
Borrowings under the Credit Agreement bear interest at a fluctuating LIBOR (which may be adjusted for certain reserve requirements), plus 1.00-2.00% depending on the current Consolidated Total Leverage Ratio (as defined in the Credit Agreement). Under certain circumstances, we may not be able to pay interest based on LIBOR. If that happens, we will be required to pay interest at the Base Rate, which is the sum of (a) the higher of (i) the Prime Rate (as publicly announced by the Agent from time to time) and (ii) the Federal Funds Rate plus 0.50%, plus (b) 0.00% to 1.00%, depending on the current Total Consolidated Leverage Ratio. The Credit Agreement also includes provisions for determining a replacement rate when LIBOR is no longer available.
At September 30, 2020, the interest rate on outstanding borrowings under the Revolving Loan was 2.50%. At September 30, 2020, we had availability of approximately $140,000 under the Revolving Loan.
We must pay a commitment fee at a rate of 0.20% per annum on the average daily unused portion of the aggregate unused revolving commitments under the Credit Agreement. We must also pay fees as specified in the Fee Letter (as defined in the Credit Agreement) and with respect to any letters of credit issued under the Credit Agreement.
The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on our ability to, subject to certain exceptions, create, incur or assume indebtedness, create or incur liens, make certain investments, merge or consolidate with another entity, make certain asset dispositions, pay dividends or other distributions to shareholders, enter into transactions with affiliates, enter into sale leaseback transactions or make capital expenditures. The Credit Agreement also requires us to satisfy certain financial covenants, including a minimum interest coverage ratio of 3.00 to 1.00. At September 30, 2020, our interest coverage ratio was 7.44 to 1.00. The Credit Agreement also requires us to maintain a consolidated total leverage ratio not to exceed 3.25 to 1.00, although such leverage ratio can be increased in connection with certain acquisitions. This ratio was increased through the Second Amendment to the Credit Agreement to 4.25 to 1.00 for this quarter, as discussed in more detail below. As of September 30, 2020, our consolidated total leverage ratio was 2.16 to 1.00.
The Credit Agreement includes customary events of default, including, among other things, payment default, covenant default, breach of representation or warranty, bankruptcy, cross-default, material ERISA events, material money judgments, and failure to maintain subsidiary guarantees. If an event of default occurs, the Agent will be entitled to take various actions, including the acceleration of amounts due under the Credit Agreement, termination of the credit facility, and all other actions permitted to be taken by a secured creditor.
Second Amendment to the Credit Agreement
On June 30, 2020, the Company entered into an amendment (Second Amendment) to the Credit Agreement. The Second Amendment provides the Company with temporary relief regarding a financial covenant (the consolidated total leverage ratio) for the period from June 30, 2020, through December 31, 2021, or such earlier date as the Company may elect (Covenant Relief Period), in return for certain increases in interest rates and fees and restrictions on certain activities of the Company, including capital expenditures, acquisitions, dividends and share repurchases. New pricing, which takes effect for the quarters ended on and after September 30, 2020, includes interest at a fluctuating LIBOR (at a floor of 75 basis points), plus 1.00% – 2.75%, along with the commitment fee ranging from 20 to 50 basis points.
During the Covenant Relief Period, the required ceiling on the Company’s consolidated total leverage ratio will be 4.25 to 1.00 for quarters ending June 30, 2020 through and including December 31, 2020 and will decline in quarterly increments to 3.25 to 1.00 for the quarter ending December 31, 2021.
As of September 30, 2020, our consolidated total leverage ratio was 2.16 to 1.00 in accordance with the Second Amendment of the Credit Agreement.
At September 30, 2020, we were in compliance with all covenants under the Credit Agreement and the Second Amendment.
Capital Requirements and Sources of Liquidity
During the nine months ended September 30, 2020 and 2019, our capital expenditures were $5,354 and $22,820, respectively. The decrease of $17,466 was driven by shifts in focuses from investments in new technology and automation in 2019 to leveraging those investments and controlling spend in 2020. Capital expenditures for the full year 2020 are expected to be approximately $10,000 to $13,000. The greater the adverse impact COVID-19 has on the business, the closer we expect to be on the lower end of this range.
We have historically relied upon cash available through credit facilities, in addition to cash from operations, to finance our working capital requirements and to support our growth. At September 30, 2020, we had immediate availability of approximately $140,000 through our Revolving Loan and another $100,000 through an accordion feature under our Credit Agreement, subject to the covenants under the Credit Agreement and Second Amendment. We regularly monitor potential capital sources, including equity and debt financings, in an effort to meet our planned capital expenditures and liquidity requirements. Our future success will be highly dependent on our ability to access outside sources of capital. We will continue to have access to the availability currently provided under the Credit Agreement as long as we remain compliant with the financial covenants. Based on our estimates of the impact of COVID-19 at this time, we expect to be in compliance with these financial covenants through 2020 and beyond.
We believe that our operating cash flow and available borrowings under the Credit Agreement are sufficient to fund our operations for 2020 when taking into consideration the estimated impacts of COVID-19 based on the information we have available at this time. However, future cash flows are subject to a number of variables, and additional capital expenditures will be required to conduct our operations. There can be no assurance that operations and other capital resources will provide cash in sufficient amounts to maintain planned or future levels of capital expenditures. In the event we make one or more acquisitions and the amount of capital required is greater than the amount we have available for acquisitions at that time, we could be required to reduce the expected level of capital expenditures and/or seek additional capital. If we seek additional capital, we may do so through borrowings under the Credit Agreement, joint ventures, asset sales, offerings of debt or equity securities or other means. We cannot guarantee that this additional capital will be available on acceptable terms or at all. If we are unable to obtain the funds we need, we may not be able to complete acquisitions that may be favorable to us or finance the capital expenditures necessary to conduct our operations.
Contractual Obligations
The following table presents our obligations and commitments to make future payments under contracts and contingent commitments at September 30, 2020:
(in thousands)
| Total | Payments Due by Period 2020 (Remainder) | 2021 – 2022 | 2023 – 2024 | Thereafter | |
|---|---|---|---|---|---|
| Long-term debt principal payment obligations (1) | $59,986 | $— | $— | $59,986 | $— |
| Forecasted interest on debt payment obligations (2) | 6,478 | 405 | 3,239 | 2,834 | — |
| Capital lease obligations | 3,126 | 184 | 1,468 | 1,248 | 226 |
| Operating lease obligations | 13,003 | 877 | 5,412 | 3,733 | 2,981 |
| Total | $82,593 | $1,466 | $10,119 | $67,801 | $3,207 |
(1) The long-term amounts in the table include principal payments under the Company’s Credit Agreement, which expires in 2024.
(2) Forecasted interest on debt obligations based on the debt balance, interest rate and unused fee as of September 30, 2020.
Market risk
As filed, 2,343 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to market risk from changes in customer forecasts, interest rates, and, to a lesser extent, commodities. To reduce such risks, we selectively use financial instruments and other proactive management techniques.
Customer Forecasts
The use and consumption of our components, products and services fluctuates depending on order forecasts we receive from our customers. These order forecasts can change dramatically from quarter to quarter dependent upon the respective markets that our customers provide products in.
Interest Rate Risk
We are exposed to interest rate risk on certain of our short- and long-term debt obligations used to finance our operations and acquisitions. We have LIBOR-based floating rate borrowings under the Credit Agreement, which exposes us to variability in interest payments due to changes in the referenced interest rates.
The amount borrowed under the Revolver Loan under the Credit Agreement was $60.0 million as of September 30, 2020. The interest rate was 2.50% as of September 30, 2020. Please see “Liquidity and Capital Resources - Amended and Restated Credit Agreement” in Part I, Item 2 of this Quarterly Report on Form 10-Q and Note 4 in the Notes to the Unaudited Condensed Consolidated Financial Statements for more specifics.
A hypothetical 100-basis-point increase in interest rates would have resulted in an additional $0.2 million of interest expense based on our variable rate debt at September 30, 2020. We do not use derivative financial instruments to manage interest risk or to speculate on future changes in interest rates. A rise in interest rates could negatively affect our cash flow.
Commodity Risk
We source a wide variety of materials and components from a network of suppliers. While such materials are generally available from numerous suppliers, commodity raw materials, such as steel, aluminum, copper, paint and paint chemicals, and other production costs are subject to price fluctuations, which could have a negative impact on our results. We strive to pass along such commodity price increases to customers to avoid profit margin erosion and in many cases utilize contracts with those customers to mitigate the impact of commodity raw material price fluctuations. As of September 30, 2020, we did not have any commodity hedging instruments in place.
Controls and procedures
As filed, 6,848 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. In designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives.
Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. As a result of the material weakness described below, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were not effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
As a newly public company, neither we nor our independent registered public accounting firm are required at this time to perform an evaluation of our internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act, and neither we nor our independent registered public accounting firm have performed such an evaluation.
During the course of the quarterly and year-end processes in 2019, we identified a material weakness in the design and operation of our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness relates to a lack of consistently documented accounting policies and procedures and a lack of formalized controls over the accounting and recording of complex and significant unusual transactions which, in the aggregate, constitute a material weakness.
We have taken numerous steps to enhance our internal control environment during 2019 and to date in 2020. While preparing for our initial public offering, as of December 31, 2018, we had identified two material weaknesses in the design and operation of our internal control over financial reporting. As of December 31, 2019, we have concluded that one of the previously identified material weaknesses has been remediated and the other has been partially remediated. The previously identified deficiencies, that represented the two material weaknesses, included the preparation and review of journal entries, a limited number of personnel with a level of GAAP accounting knowledge commensurate with our financial reporting requirements and certain information technology general controls specific to segregation of duties, systems access and change management processes. However, deficiencies in our control environment, specifically deficiencies related to a lack of consistently documented accounting policies and procedures and a lack of formalized controls over the accounting and recording of complex and significant unusual transactions, which we have collectively determined aggregate to a material weakness, remained as of September 30, 2020. We are currently enacting a number of steps to enhance our control over financial reporting and address this material weakness, including: enhancing our internal review procedures during the financial statement close process, and designing and implementing consistent policies throughout the Company; however, our current efforts to design and implement effective controls may not be sufficient to remediate the material weakness described above or prevent future material weaknesses or other deficiencies from occurring. Despite these actions, we may identify additional material weaknesses in our internal control over financial reporting in the future.
If we fail to effectively remediate this material weakness in our internal control over financial reporting, if we identify future material weaknesses in our internal control over financial reporting or if we are unable to comply with the demands that will be placed upon us as a public company, including the requirements of Section 404 of the Sarbanes-Oxley Act, in a timely manner, we may be unable to accurately report our financial results, or report them within the timeframes required by the SEC. In addition, if we are unable to assert that our internal control over financial reporting is effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, when required, investors may lose confidence in the accuracy and completeness of our financial reports, we may face restricted access to the capital markets and our stock price may be adversely affected.
Commencing with our Annual Report on Form 10-K for the year ending December 31, 2020 we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting in our Form 10-K filing for that year, as required by Section 404 of the Sarbanes Oxley Act. We have expended significant resources in developing the necessary documentation and testing procedures required by Section 404. If we fail to implement the requirements of Section 404 in a timely manner, regulatory authorities such as the SEC or the Public Company Accounting Oversight Board, might subject us to sanctions or investigation. We cannot be certain that the actions we have undertaken to improve our internal controls over financial reporting will be sufficient, or that we will be able to implement our planned processes and procedures in a timely manner.
Risk factors
As filed, 451 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC on March 2, 2020, other than as such were previously supplemented and amended in Part II, Item 1A, “Risk Factors” in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020 which was filed with the SEC on May 6, 2020.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-01 to 2020-09-30 | $91.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-01-01 to 2020-09-30 | $262.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-07-01 to 2020-09-30 | $81.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2020-01-01 to 2020-09-30 | $241.8m | us-gaap:CostOfRevenue |
| Operating income | 3 months2020-07-01 to 2020-09-30 | $280.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-01 to 2020-09-30 | −$7.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-07-01 to 2020-09-30 | $647.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2020-01-01 to 2020-09-30 | $2.1m | us-gaap:InterestExpense |
| Income tax | 3 months2020-07-01 to 2020-09-30 | $733.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-30 | −$1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-01 to 2020-09-30 | −$1.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | −$8.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | $19.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-01-01 to 2020-09-30 | $5.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2020-01-01 to 2020-09-30 | $2.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-09-30 | $110.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-09-30 | $93.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-09-30 | $343.9m | us-gaap:Assets |
| Current liabilities | At period end2020-09-30 | $44.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-09-30 | $145.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-09-30 | $198.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-20-050034. Last ingested by Listed: Nov 5, 2026, 13:59 ET. Listed shows no prices and gives no investment advice.